An observational study in Frailty, Dementia and Depression, sponsored by Gulhane Training and Research Hospital. Enrolling by invitation at 1 site in Turkey. Open to participants aged 80 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-06.
Sponsored by Gulhane Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 83 studies in Frailty with a site in Turkey — 24 open to participants now, 27 under way, none of them phase 3. Frailty · Turkey.
Among the 83 studies in Frailty with a site in Turkey, this one is the 2nd largest by planned enrollment of the 67 observational ones that give a count, is one of 14 that started in 2023, is one of 67 observational ones, reaches primary completion later than 5 of the 26 other live ones, and was the 22nd registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →24 of the 83 studies in Frailty with a site in Turkey are open now. Recruiting first, the newest first:
Konya City Hospital · Sites in Turkey
Ages 65+
Kocaeli City Hospital · Sites in Turkey
Ages 65+
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Konya City Hospital · Sites in Turkey
Ages 18+
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Sites in Turkey
Ages 65–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 80 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
83 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 14 started in 2023.
This study's planned enrollment of 2,000 is above the median of 225 across 495 observational studies indexed under Frailty.
Median enrollment 64 across the 16 interventional studies, 138 across the 67 observational. Of the 51 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 83 has an industry lead sponsor. The 10 most frequent:
Gulhane Training and Research Hospital is the lead sponsor of 44 studies on the registry; 8 are open to participants now.
Gulhane Training and Research Hospital has 1 study filed under Frailty — fewer than ten, so there is no comparison to draw.
12 of the studies in Frailty with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07813702MERT UYSALURINARY INCONTINENCE AND GERIATRIC SYNDROMES | 2026-11 |
| NCT07677072Kanuni Sultan Suleyman Training and Research HospitalCan Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women? | 2026-12-01 |
| NCT07463352Duzce UniversityPreoperative Oral Nutrition And Outcomes In Frail Elderly Patients With Femur Fractures | 2027-01-01 |
| NCT07458048Istanbul University - CerrahpasaComparıson of the Effıcacy of Conventıonal Exercıse and Pılates ın Pre-fraıl and Fraıl Older Adults | 2027-02 |
| NCT07642765Konya City HospitalEASIX Score and Post-Induction Hypotension in Frail Patients Undergoing Non-Cardiac Surgery | 2027-02-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 83 studies in Frailty with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Depending on the YASAM project which was established to home-visit evaluate community-dwelling older adults (80 years of age and over), we aimed to determine the prevalence (prevalence) of geriatric syndromes (dependence, frailty, malnutrition, depression, dementia, comorbidity burden, polypharmacy) in these individuals and to determine possible changes in the follow-up of the patients during the 2-year follow-up period. (HEAVEN trial)
Individuals over the age of 80 who will participate in the YASAM project will first be informed by phone and their appointments will be made. Subsequently, a home visit will be conducted after obtaining verbal and written consent from the patients and their relatives.
The chronic diseases and medications of the patients will be questioned and controlled from the electronic data set. To determine the level of frailty and dependency, the Katz, Lawton-Brody, and Clinical Frailty scales will be filled in, respectively, by the previously trained health personnel, by interviewing their relatives. Mini-Cog, Mini Mental Status Assessment, Mini Nutrition Assessment, and Geriatric Depression (Yesavage) Assessments will be planned. According to dependency status, individuals will be re-evaluated in the 1st or 2nd month. If the patients are fully independent, control follow-up is planned in the 3rd month. Written file records will be created by obtaining the consent of the patients and their relatives at each patient visit. Each team will be responsible for the follow-up of 300 patients. It is planned to include a total of 6000 individuals in the first phase, which is carried out in 20 centers throughout the province of Balıkesir and whose coordination center is Atatürk city hospital. In the follow-ups, it is planned to include the whole cohort consisting of 40 thousand individuals over the age of 80, by increasing the number of teams. The short-term results of the patient's follow-up (1st, 3rd, and 6th-month results), changes in mortality, addiction, frailty level, and changes in nutrition and cognitive functions within the specified period will be evaluated as short-term results. It is aimed to record the long-term outcomes (1st and 2nd year) of the same variables.
Since the whole population will be included in the study, sample size and power analysis were not performed.
It is planned to include a total of 6000 individuals in the first phase, which is carried out in 20 centers throughout the province of Balıkesir (rural and central area) and whose coordination center is Balikesir Atatürk City Hospital. In the follow-ups, it is planned to include the whole cohort consisting of individuals over the age of 40 thousand 80, by increasing the number of teams.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Comprehensive Geriatric Assessments include functional status, fraility comorbidity, cognition, mental health, social support, nutrition, and geriatric syndromes
Short term Healthy Aging status (mortality)
Outcomes were evaluated according to the national electronic database.
Time frame: 1-,3-,6- month
Short term Healthy Aging status (changes dependency )
Outcomes were evaluated according to the specific test Katz scales the 1 is minimum and 6 is maximum value for scale, and higher scores mean a better outcome, higher scores mean a better outcome for dependency)
Time frame: 1-,3-,6- month
Short term Healthy Aging status (changes in frailty level)
Outcomes were evaluated according to the specific test (Fraility via Clinical fraility scales the 1 is minimum and 9 is maximum value for scale, and higher scores mean a worse outcome).
Time frame: 1-,3-,6- month
Short term Healthy Aging status (changes in nutrition)
Outcomes were evaluated according to the specific test (MNA scale for nutritional status the 0 is minimum and 14 is maximum value for scale, and higher scores mean a better outcome).
Time frame: 1-,3-,6- month
Short term Healthy Aging status (changes in cognitive functions)
Outcomes were evaluated according to the specific test (cognitive functions with MMSE scale, the 0 is minimum and 30 is maximum value for scale, and higher scores mean a better outcome)
Time frame: 1-,3-,6- month
Short term Healthy Aging status (changes in mood)
Outcomes were evaluated according to the specific test (Outcomes were evaluated according to the specific test ( Yesavage for Depression status the 0 is minimum and 15 is maximum value for scale, and higher scores mean a worse outcome)
Time frame: 1-,3-,6- month
Short term Healthy Aging status (changes in mobility status)
Outcomes were evaluated according to the specific test (Chair stand test higher scores (\>13,5 seconds) means a worse outcome for mobility status).
Time frame: 1-,3-,6- month
Long term Healthy Aging status (mortality)
Outcomes were evaluated according to the national electronic database.
Time frame: 1- and 2- year
Long term Healthy Aging status (changes dependency )
Outcomes were evaluated according to the specific test Katz scales the 1 is minimum and 6 is maximum value for scale, and higher scores mean a better outcome, higher scores mean a better outcome for dependency)
Time frame: 1- and 2- year
Long term Healthy Aging status (changes in frailty level)
Outcomes were evaluated according to the specific test (Fraility via Clinical fraility scales the 1 is minimum and 9 is maximum value for scale, and higher scores mean a worse outcome.)
Time frame: 1- and 2- year
Long term Healthy Aging status (changes in nutrition)
Outcomes were evaluated according to the specific test (MNA scale for nutritional status the 1 is minimum and 14 is maximum value for scale, and higher scores mean a better outcome).
Time frame: 1- and 2- year
Long term Healthy Aging status (changes in cognitive functions)
Outcomes were evaluated according to the specific test (cognitive functions with MMSE scale, the 0 is minimum and 30 is maximum value for scale, and higher scores mean a better outcome).
Time frame: 1- and 2- year
Long term Healthy Aging status (changes in mood)
Outcomes were evaluated according to the specific test ( Yesavage scale for Depression status the 0 is minimum and 15 is maximum value for scale, and higher scores mean a worse outcome).
Time frame: 1- and 2- year
Long term Healthy Aging status (changes in mobility status)
Outcomes were evaluated according to the specific test (Outcomes were evaluated according to the specific test (Chair stand test higher scores (\>13,5 seconds) means a worse outcome for mobility status).
Time frame: 1- and 2- year
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jun 2023 (actual). Primary completion is estimated for Dec 2024, 17 months after the start.
Of 291 non-industry observational studies under Frailty, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 17 months is below that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gulhane Training and Research Hospital